https://orcid.org/0000-0002-8703-4611
References
- Wallin MT, Culpepper WJ, Nichols E, et al. Global, regional, and national burden of multiple sclerosis 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(3):269–285.
- Compston A, Coles A. Multiple sclerosis. Lancet Lond Engl. 2008;372(9648):1502–1517.
- Litwiller SE, Frohman EM, Zimmern PE. Multiple sclerosis and the urologist. J Urol. 1999;161(3):743–757.
- Giannantoni A, Scivoletto G, Di Stasi SM, et al. Lower urinary tract dysfunction and disability status in patients with multiple sclerosis. Arch Phys Med Rehabil. 1999;80(4):437–441.
- Di Filippo M, Proietti S, Gaetani L, et al. Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis. Eur J Neurol. 2014;21(4):648–653.
- Averbeck MA, Iacovelli V, Panicker J, et al. Urodynamics in patients with multiple sclerosis: a consensus statement from a urodynamic experts working group. Neurourol Urodyn. 2020;39(1):73–82.
- de Sèze M, Ruffion A, Denys P, et al. The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Mult Scler. 2007;13(7):915–928.
- Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.
- Ghasemi N, Razavi S, Nikzad E. Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy. Cell J Yakhteh. 2017;19(1):1–10.
- Types of MS [Internet]. National Multiple Sclerosis Society; [cited 2021 Jan 28]. Available from: http://www.nationalmssociety.org/What-is-MS/Types-of-MS.
- Joy JE, Richard B, Johnston J. Kurtzke’s Expanded Disability Status Scale (EDSS). National Academies Press (US). 2001; [cited 2021 Jan 28]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK222389/.
- Chuang F-C, Hsiao S-M, Kuo H-C. The overactive bladder symptom score, international prostate symptom score-storage subscore, and urgency severity score in patients with overactive bladder and hypersensitive bladder: which scoring system is best? Int Neurourol J. 2018;22(2):99–106.
- Liao C-H, Chung S-D, Kuo H-C. Diagnostic value of international prostate symptom score voiding-to-storage subscore ratio in male lower urinary tract symptoms. Int J Clin Pract. 2011 May;65(5):552–558.
- Hsiao S-M, Lin H-H, Kuo H-C. International prostate symptom score for assessing lower urinary tract dysfunction in women. Int Urogynecol J. 2013;24(2):263–267.
- Amarenco G, de Sèze M, Ruffion A, et al. Clinical and urodynamic evaluations of urinary disorders in multiple sclerosis. Ann Phys Rehabil Med. 2014;57(5):277–287.
- Bonniaud V, Bryant D, Parratte B, et al. Development and validation of the short form of a urinary quality of life questionnaire: SF-Qualiveen. J Urol. 2008;180(6):2592–2598.
- Rosier PFWM, Schaefer W, Lose G, et al. International continence society good urodynamic practices and terms 2016: urodynamics, uroflowmetry, cystometry, and pressure-flow study. Neurourol Urodyn. 2017;36(5):1243–1260.
- Lemack GE, Hawker K, Frohman E. Incidence of upper tract abnormalities in patients with neurovesical dysfunction secondary to multiple sclerosis: analysis of risk factors at initial urologic evaluation. Urology. 2005;65(5):854–857.
- Amarenco G, Chartier-Kastler E, Denys P, et al. First-line urological evaluation in multiple sclerosis: validation of a specific decision-making algorithm. Mult Scler. 2013;19(14):1931–1937.
- Wang T, Huang W, Zhang Y. Clinical characteristics and urodynamic analysis of urinary dysfunction in multiple sclerosis. Chin Med J. 2016;129(6):645–650.
- Dillon BE, Lemack GE. Urodynamics in the evaluation of the patient with multiple sclerosis: when are they helpful and how do we use them? Urol Clin North Am. 2014;41(3):439–444.